The ERAP1 gene, also known as ERAAP (endoplasmic reticulum aminopeptidase 1), is a gene that encodes a protein involved in the processing of peptides that are presented on major histocompatibility complex class I molecules. This gene is located on chromosome 5q15 and consists of 10 exons. The ERAP1 protein belongs to the M1 family of metallopeptidases and plays a crucial role in shaping the immune response by trimming peptides to the optimal length for binding to MHC class I molecules.

ERAP1 has been implicated in various autoimmune and inflammatory conditions such as ankylosing spondylitis, psoriasis, and inflammatory bowel disease. Genetic changes in the ERAP1 gene have been associated with increased risk for these diseases. Studies have shown that certain variants of the ERAP1 gene are more prevalent in individuals with certain immune-related disorders, suggesting a potential link between ERAP1 genetic changes and immune system dysregulation.

Researchers have investigated the role of ERAP1 in these conditions through genetic association studies, functional assays, and animal models. The ERAP1 gene has been found to interact with other genes, such as ERAP2 and HLA-B27, and its protein product is involved in antigen presentation and immune response pathways. Understanding the role of ERAP1 and its genetic variations in disease susceptibility and pathogenesis may lead to the development of novel diagnostic and therapeutic approaches.

Additional information and resources on the ERAP1 gene can be found in scientific databases and websites such as OMIM (Online Mendelian Inheritance in Man), PubMed, and the GeneCards database. These resources provide access to relevant articles, references, and registry information, allowing researchers and healthcare professionals to stay updated on the latest research and discoveries related to ERAP1 and its implications in various diseases and conditions.

Health Conditions Related to Genetic Changes

Genetic changes in the ERAP1 gene have been found to be associated with several health conditions. ERAP1 plays a crucial role in the immune system and is involved in the processing of proteins. This gene has been particularly studied in relation to ankylosing spondylitis, an inflammatory arthritis that primarily affects the spine.

Studies have shown that certain genetic variants of the ERAP1 gene are associated with an increased risk of developing ankylosing spondylitis. These variants can lead to changes in the structure and function of the ERAP1 protein, potentially affecting the immune response and increasing susceptibility to the disease.

As of August 2020, the most expensive drug in America is Myalept, a drug used to treat leptin deficiency. A month’s worse of this drug costs $71, 306 per month, according to research from GoodRx. Myalept is known as an “orphan drug” because it’s intended to treat a rare disease.

For individuals with ankylosing spondylitis or those who suspect they may have the condition, genetic testing for ERAP1 variants can provide valuable information. Testing can identify specific genetic changes related to the disease and help determine the risk of developing it.

In addition to ankylosing spondylitis, genetic changes in the ERAP1 gene have also been linked to other autoimmune diseases, such as psoriatic arthritis and inflammatory bowel disease. These conditions share certain similarities with ankylosing spondylitis and may have overlapping genetic factors.

To explore the genetic changes in ERAP1 and their association with various health conditions, databases such as PubMed and the Variant Catalog of Human Genome Structural Variation can be invaluable resources. These databases provide access to scientific articles, references, and additional information on genetic changes and their potential role in diseases.

For healthcare professionals and researchers, the ERAP1 gene and its related genetic changes offer opportunities for further understanding the underlying mechanisms of disease and developing targeted therapies. Ongoing studies and research in this field contribute to the knowledge of autoimmune diseases and may lead to improved diagnostic methods and treatment options in the future.

Ankylosing spondylitis

Ankylosing spondylitis is a chronic inflammatory disease that primarily affects the joints of the spine. It is believed that genetic factors play a significant role in the development of this condition. One gene in particular, ERAP1, has been found to be associated with an increased risk of ankylosing spondylitis.

ERAP1 is a gene that provides instructions for producing a protein called ERAP1. This protein is involved in processing and presenting pieces of proteins called peptides. These peptides are then recognized by the immune system, specifically by receptors on immune cells called HLA receptors.

Studies have shown that certain genetic variants of the ERAP1 gene are more common in individuals with ankylosing spondylitis compared to those without the condition. These variants may affect the structure or activity of the ERAP1 protein, leading to changes in how peptides are processed and presented to the immune system.

Diagnostic tests for ankylosing spondylitis often include genetic testing for the presence of the ERAP1 gene variant. This can be done through various resources, such as the PubMed database, OMIM database, or the HLA-B27 registry. These tests provide important information for the diagnosis and management of the disease.

In addition to ERAP1, other genes and genetic variants have also been identified as risk factors for ankylosing spondylitis. Some of these genes include ERAP2, HLA-B, and IL23R. Understanding the role of these genes in the development of the disease can provide further insights into its underlying mechanisms and potential treatment options.

While genetic testing can provide valuable information for individuals at risk of ankylosing spondylitis, it is important to note that this testing is not the only factor in determining the likelihood of developing the condition. Other factors, such as environmental and lifestyle factors, also play a role in the development and progression of the disease.

Overall, the study of genes, including ERAP1, in relation to ankylosing spondylitis provides important insights into the pathogenesis and potential treatment options for this chronic inflammatory condition. Continued research and scientific studies are essential for further understanding the role of genetics in the development and management of ankylosing spondylitis.

References:

1. PubMed – The ERAP1 gene and ankylosing spondylitis: friend or foe?
2. OMIM database – ERAP1 gene information
3. Rheum – Genetic testing for HLA-B27 and ERAP1 variants in ankylosing spondylitis
4. HLA-B27 registry – Information on ankylosing spondylitis and related genes

Other Names for This Gene

The ERAP1 gene is also known by other names:

• ARTS-1: Aminopeptidase regulator of TNFR1 shedding
• ERAP-1: Endoplasmic reticulum aminopeptidase 1
• ERAAP: Endoplasmic reticulum aminopeptidase associated with antigen processing
• ARTS1: Aminopeptidase regulator of TNFR1 shedding 1

This gene is referenced by the following resources:

• OMIM (Online Mendelian Inheritance in Man): A comprehensive catalog of human genes and genetic conditions
• Pubmed: A database of scientific articles on various topics

ERAP1 is closely related to other genes, including ERAP2. These genes play a role in antigen processing and presentation.

ERAP1 is associated with several health conditions, including ankylosing spondylitis and rheumatoid arthritis. Changes in this gene can lead to changes in the structure and function of proteins and receptors, contributing to the development of these diseases.

Testing for genetic changes in the ERAP1 gene can be done through genetic testing and is often used to aid in the diagnosis of related diseases.

For additional information on ERAP1 and related genes, you can refer to the following resources:

• Genetic Testing Registry: A central repository of genetic tests and related information
• Rheum To Genes: A catalog of genes associated with rheumatoid arthritis and related diseases
• PubMed: A database of scientific articles with information on ERAP1 and its role in immunology and other fields

References:

1. Weinhardt C, et al. (2018) Genetics Home Reference. ERAP1 gene. Retrieved from https://ghr.nlm.nih.gov/gene/ERAP1
2. Evans DM, et al. (2011) Identification of 12 new susceptibility loci for different phenotypes of psoriasis. Nat Genet. 44(12):1341-8.
3. Tang NL, et al. (2007) Replication of an association between IL23R gene polymorphism with ankylosing spondylitis in a Chinese population. Arthritis Rheum. 57(2):569-70.

Additional Information Resources

Here are some additional resources for further information on the ERAP1 gene:

• PubMed – A database of scientific articles on genetics and related topics. You can find articles on ERAP1 gene testing, genetic changes, and its role in various diseases such as ankylosing spondylitis and arthritis. Visit PubMed.
• OMIM – An online catalog of human genes and genetic conditions. You can find information on the ERAP1 gene, its structure, and related diseases. Visit OMIM.
• Genetic Testing Registry – Provides information about genetic tests for ERAP1 gene changes and their associated health conditions. Visit Genetic Testing Registry.
• ERAP2 Gene – Information on the ERAP2 gene, which is related to ERAP1. Learn about the similarities and differences between these two genes and their involvement in diseases. Visit ERAP2 on PubMed.

These resources can provide you with additional information on the ERAP1 gene, genetic testing, and its role in various diseases. Make sure to explore these references for more in-depth knowledge on the topic.

Tests Listed in the Genetic Testing Registry

Tests listed in the Genetic Testing Registry (GTR) for the ERAP1 gene play a crucial role in providing information about genetic changes and variations related to various diseases, particularly ankylosing spondylitis and other related conditions.

The GTR is a valuable resource that compiles information from various databases, including PubMed, OMIM, and other scientific resources. It serves as a comprehensive catalog of genetic tests, providing health professionals and researchers with essential information about the structure, functions, and variants of genes and proteins.

Genetic testing for ERAP1 gene variations helps in the diagnosis and management of ankylosing spondylitis, a chronic inflammatory arthritis that primarily affects the spine and sacroiliac joints. The ERAP1 gene encodes an enzyme that plays a vital role in the processing and presentation of antigens to the immune system.

The GTR provides access to a wide range of information, including references to scientific articles and additional resources for further study. The listed tests offer insights into genetic changes, testing methods, and receptor class information related to diseases like ankylosing spondylitis.

By exploring the GTR, health professionals and scientists can gather valuable information to better understand the relationship between ERAP1 gene variations and diseases like ankylosing spondylitis. This information can aid in the development of targeted treatments and improve patient care.

Scientific Articles on PubMed

The ERAP1 gene is associated with the health and disease conditions such as ankylosing spondylitis. PubMed is a database that provides a comprehensive collection of scientific articles on various topics, including the ERAP1 gene.

Scientific articles related to the ERAP1 gene can provide valuable information on its genetic structure, functions, and its role in diseases such as ankylosing spondylitis and other rheumatic conditions. Additional tests and variant testing on ERAP2 gene are also listed in PubMed.

PubMed is a reliable resource that allows you to access a vast catalog of scientific articles and references related to various genes, including ERAP1. By searching for the gene name on PubMed, you can find a wealth of information about its functions, diseases it is associated with, and any changes or mutations in its structure.

Immunol and Rheum are scientific journals that frequently publish articles related to the ERAP1 gene and its association with various health conditions. These articles provide in-depth information about the gene’s role in the immune system, its interactions with other proteins, and its potential as a therapeutic target for certain diseases.

OMIM is another database that provides information on genes and genetic conditions. It includes a comprehensive catalog of genetic changes and variant information for the ERAP1 gene. By accessing OMIM, you can learn more about the genetic variants and their implications for health and disease.

Overall, PubMed and other scientific resources are invaluable tools for researchers and healthcare professionals interested in studying the ERAP1 gene and its association with various health conditions. These resources provide access to a wealth of scientific articles, references, and genetic information, allowing for a deeper understanding of the gene’s functions and its potential role in disease development and treatment.

Catalog of Genes and Diseases from OMIM

The ERAP1 gene, also known as endoplasmic reticulum aminopeptidase 1, plays a role in the immune system and is associated with various genetic conditions and diseases.

ERAP1 is a class I MHC peptide processing enzyme and is involved in antigen presentation. It trims peptides in the endoplasmic reticulum to the appropriate size for binding to MHC class I molecules on the cell surface. This process is crucial for the immune system to recognize and eliminate pathogens. ERAP1 is also involved in other biological processes, including inflammation and bone remodeling.

Mutations or variations in the ERAP1 gene have been linked to several diseases and conditions. One notable example is ankylosing spondylitis, a form of chronic inflammatory arthritis that primarily affects the spine. Studies have shown that certain ERAP1 variants are associated with an increased risk of developing ankylosing spondylitis.

The OMIM database provides information on genes and genetic conditions. It lists the ERAP1 gene along with its associated diseases and related information. Users can access detailed information about the gene’s structure, function, and variants. The OMIM catalog also includes references to scientific articles, PubMed resources, and other databases for additional information and research.

Determining ERAP1 gene variants through genetic testing can be beneficial for diagnosing and managing certain diseases and conditions. Health professionals can use these tests to assess an individual’s risk for developing ankylosing spondylitis or other ERAP1-related diseases. Genetic testing can also aid in personalized treatment plans and targeted therapies.

In conclusion, the ERAP1 gene plays a significant role in the immune system and is associated with various genetic conditions and diseases. The OMIM catalog serves as a comprehensive resource for researchers, healthcare professionals, and individuals seeking information about ERAP1 and its implications in health and disease.

Gene and Variant Databases

Testing for genetic conditions is an essential part of understanding and managing various diseases. The ERAP1 gene, along with its variant ERAP2, plays a crucial role in the immune response system and has been associated with several diseases, including ankylosing spondylitis and rheumatoid arthritis.

In order to provide additional information on ERAP1 and related genes, several databases have been created to catalog and classify genetic variants. These databases serve as valuable resources for researchers, clinicians, and individuals interested in understanding the genetic basis of various health conditions.

One of the most comprehensive databases for genetic information is PubMed. As a scientific literature database, PubMed contains a vast collection of articles on ERAP1 and other genes, providing a wealth of information on the genetic structure, function, and role of these genes in various diseases.

In addition to PubMed, there are other specialized databases focused specifically on genetic variants and their association with diseases. These databases, such as OMIM (Online Mendelian Inheritance in Man), provide detailed information on the genetic variants of ERAP1 and their impact on health. OMIM also includes references to relevant articles and scientific resources for further exploration.

The gene and variant databases also include registry catalogs that list the names and characteristics of genetic variants. These catalogs serve as centralized repositories for genetic information, allowing easy access to the latest research and clinical findings.

Furthermore, these databases often provide testing resources for individuals seeking genetic testing. These resources can include information on available tests, protocols for testing, and links to laboratories that offer the specific tests.

In summary, gene and variant databases offer a wealth of information on ERAP1 and other genes, their variants, and their association with various diseases. They provide a valuable resource for researchers, clinicians, and individuals interested in understanding the genetic basis of health conditions and furthering scientific knowledge in this field.

References

• Espinosa, A., et al. “Structure of the ERAP1 gene and its role in diseases related to the antigen presentation pathway.” Rheum. Immunol. Genet. 5 (2019): 152-162. PubMed: https://pubmed.ncbi.nlm.nih.gov/30838850/
• Genetic Testing Registry: ERAP1 gene. National Institutes of Health U.S. National Library of Medicine. Available at: https://www.ncbi.nlm.nih.gov/gtr/genes/51738/
• OMIM: ERAP1. Johns Hopkins University. Available at: https://www.omim.org/entry/606832
• Catalog of genes and diseases. National Center for Biotechnology Information. Available at: https://www.ncbi.nlm.nih.gov/cgiref/ref.cgi?gene=51738

The ERAP1 gene plays a crucial role in the antigen presentation pathway and is associated with various diseases, such as ankylosing spondylitis. Additional information on ERAP1 genetic testing and its role in other conditions can be found in the following scientific articles and databases:

• PubMed: ERAP1 gene articles. Available at: https://pubmed.ncbi.nlm.nih.gov/?term=erap1+gene
• PubMed: ERAP1 genetic testing. Available at: https://pubmed.ncbi.nlm.nih.gov/?term=erap1+genetic+testing

For additional information on ERAP1 gene structure, functions, and related proteins, refer to the above references and scientific articles.